Radiance Therapeutics
Pre-clinicalRadiance Therapeutics develops targeted radiopharmaceuticals for treating cancer using precision radiotherapy approaches.
Founded
2021
Focus
Drug Delivery
About
Radiance Therapeutics develops targeted radiopharmaceuticals for treating cancer using precision radiotherapy approaches.
Funding History
2Total raised: $21.5M
Series A$17.5MNovo HoldingsOct 15, 2023
Seed$4MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile